SCA
IDXX icon

Snowden Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Snowden Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$539K Sell
959
-386
-29% -$248K 0.01% 764
2025
Q4 		$910K Sell
1,345
-279
-17% -$190K 0.02% 566
2025
Q3 		$1.04M Sell
1,624
-148
-8% -$89.8K 0.03% 515
2025
Q2 		$950K Buy
1,772
+782
+79% +$374K 0.03% 539
2025
Q1 		$416K Buy
990
+37
+4% +$16.1K 0.01% 830
2024
Q4 		$394K Sell
953
-1,023
-52% -$449K 0.01% 872
2024
Q3 		$998K Sell
1,976
-175
-8% -$85K 0.03% 519
2024
Q2 		$1.05M Buy
2,151
+1,409
+190% +$707K 0.03% 493
2024
Q1 		$401K Buy
742
+290
+64% +$158K 0.01% 859
2023
Q4 		$251K Buy
+452
New +$212K 0.01% 989
2022
Q3 		– Sell
-605
Closed -$212K – 1142
2022
Q2 		$212K Sell
605
-26
-4% -$10.6K 0.01% 1023
2022
Q1 		$345K Sell
631
-11,939
-95% -$6.28M 0.01% 762
2021
Q4 		$8.28M Buy
12,570
+83
+0.7% +$52.1K 0.42% 50
2021
Q3 		$7.77M Buy
12,487
+687
+6% +$462K 0.39% 56
2021
Q2 		$7.45M Buy
11,800
+1,438
+14% +$794K 0.37% 55
2021
Q1 		$5.07M Buy
+10,362
New +$5.19M 0.29% 93

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Snowden Capital Advisors's IDXX Position: Q1 2026 in Review

Snowden Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 29% in Q1 2026, selling an estimated $248K and leaving 959 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #764.

Snowden Capital Advisors first reported a position in IDXX in Q1 2021 and has held it in 16 quarters since. The position peaked at $8.28M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Snowden Capital Advisors held 959 shares of Idexx Laboratories worth $539K as of Q1 2026.
  • Snowden Capital Advisors sold 386 Idexx Laboratories shares in Q1 2026, an estimated $248K.
  • Idexx Laboratories made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #764 holding.
  • Snowden Capital Advisors first reported a position in Idexx Laboratories in Q1 2021 and has held it in 16 quarters since.
  • Snowden Capital Advisors's Idexx Laboratories position peaked at $8.28M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.